Phase 1 trial of p28 (NSC745104), a non-HDM2 mediated peptide inhibitor of p53 ubiquitination in children with recurrent or progressive CNS tumors: A final report from the Pediatric Brain Tumor Consortium.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 10059-10059 ◽  
Author(s):  
Rishi Ramesh Lulla ◽  
Stewart Goldman ◽  
Craig Beattie ◽  
Tohru Yamada ◽  
Ian Pollack ◽  
...  
2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 10065-10065 ◽  
Author(s):  
Anuradha Banerjee ◽  
Regina Jakacki ◽  
Arzu Onar-Thomas ◽  
Shengjie Wu ◽  
Theodore Nicolaides ◽  
...  

Cancer ◽  
2016 ◽  
Vol 122 (20) ◽  
pp. 3207-3214 ◽  
Author(s):  
Ajay K. Nooka ◽  
Madhusmita Behera ◽  
Sagar Lonial ◽  
Margie D. Dixon ◽  
Suresh S. Ramalingam ◽  
...  

2017 ◽  
Vol 19 (suppl_4) ◽  
pp. iv54-iv54 ◽  
Author(s):  
Amy Lee ◽  
Bonnie Cole ◽  
Sandra Poliachik ◽  
Jeff Ojemann ◽  
Dennis Miller ◽  
...  

2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii466-iii466
Author(s):  
Manisha Jogendran ◽  
Rebecca Ronsley ◽  
Ran D Goldman ◽  
Sylvia Cheng

Abstract Delayed diagnosis of CNS tumors in children is well documented, partially due to challenges in recognizing rare diagnoses. Our objective was to describe Canadian family physicians’ attitudes and confidence in diagnosing and managing pediatric CNS tumors. A standardized questionnaire was administered at a Canadian national family physicians’ conference. Items were based on observations from our institutional study of prediagnostic symptomatic interval in pediatric CNS tumors. 449 surveys were completed. 302/443 (68%) physicians practice in cities. 153/447 (34%) report encountering parents that inquire about their children having brain tumors. 261/449 (58%) have not managed a pediatric brain tumor. 153/447 (34%) report they are not confident, 255/447 (57%) somewhat confident and 39/447 (9%) confident in managing a suspected brain tumor in a stable child. 259/447 (58%) would refer directly to a hospital/specialist. The reported median time for suspicion of a brain tumor was 8–14 days for children with vomiting and/or headache and 1 day for children with seizure and/or ataxia. 410/447 (97%) report not knowing any guidelines to help with management. 235/447 (53%) suggested barriers they experience to include 52/235 (22%) wait times for imaging/specialists, 37/235 (16%) geographical location of the child, 27/235 (12%) knowledge, 25/235 (11%) access to imaging/specialist, and 15/235 (6%) patient-related factors or system barriers, and 8/235 (3%) specialist attitudes. 68/235 (29%) identified no barriers in their practice. This study provides insight into family physicians’ perceived challenges and barriers in diagnosing and managing new suspected pediatric CNS tumors. Educational effort and overcoming systemic perceived barriers may increase physicians’ confidence.


2012 ◽  
Vol 60 (4) ◽  
pp. 627-632 ◽  
Author(s):  
Susan M. Blaney ◽  
Michael Tagen ◽  
Arzu Onar-Thomas ◽  
Stacey L. Berg ◽  
Sri Gururangan ◽  
...  

2014 ◽  
Vol 16 (12) ◽  
pp. 1661-1668 ◽  
Author(s):  
Jack M. Su ◽  
Patrick Thompson ◽  
Adekunle Adesina ◽  
Xiao-Nan Li ◽  
Lindsay Kilburn ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document